What other stocks do shareholders of 1724525 (ADN.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 1724525 (ADN.L) investors own include Babcock International Group (BAB) , Bayerische Motoren Werke Aktiengesellschaft (BMW) , Centrica (CNA) , Lloyds Banking Group (LLOY) , Barclays (BARC) , The Berkeley Group (BKG) , Oshkosh (OSK) , Vanquis Banking Group (PFG) , Rio Tinto Group (RIO) and Aviva (AV) .

How do I buy shares of 1724525 (ADN.L)?

Shares of ADN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:ADN

1724525 (ADN.L) (ADN) Share Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free ADN Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 3.09 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get 1724525 (ADN.L) alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About 1724525 (ADN.L) Stock (LON:ADN)

Aberdeen Asset Management PLC is a United Kingdom-based asset manager. The Company operates through asset management for reporting and control purposes. The Company is managed as a single asset management business, with multiple investment strategies of equities, fixed income and property, complemented by a solutions business, which provides multi asset, alternatives and quantitative investment capabilities. These strategies are managed across a range of products, distribution channels and geographic regions. The Company holds investments in seed capital investments, investments in certain Aberdeen-managed funds to hedge deferred fund awards and other investments. The Company operates in approximately 20 countries. Its operations span across Asia Pacific, Australia, the United Kingdom, the United States, the Middle East and Europe, among others.

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

Find out more here >>>

ADN Stock News Headlines

July 1, 2023 | health.usnews.com

Dr. Russell G. Hirano

November 15, 2022 | finance.yahoo.com

Advent Technologies Holdings, Inc. (ADN)

See More Headlines

Receive ADN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 1724525 (ADN.L) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Manufacturing
Industry: Optical Instrument & Lens Manufacturing
Sub-Industry: N/A
Current Symbol: LON:ADN
CUSIP: N/A
CIK: N/A
Web: www.aberdeen-asset.com
Phone: +44-1224-631999
Fax: N/A
Employees: 57
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Martin James Gilbert LL.D.
M.D., Chief Executive, Executive Director
Andrew A. Laing
Deputy Chief Executive, Executive Director
Bever Hendry
Co-Head of Americas and Chief Financial Officer
W. J. Rattray
Finance Director, Executive Director
Martin Jennings
Chief Executive Officer Parmenion and Head of Aberdeen Digital
Avril McLean
Chief Technology Officer
Gordon H. Brough
General Counsel
Hugh Young
Managing Director of Aberdeen Asset Management Asia, Executive Director
Roderick MacLeod MacRae
Group Head - Risk, Executive Director
Kerry Christie
Global Head - Human Resources

Key Competitors

View All Competitors

ADN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of 1724525 (ADN.L) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other 1724525 (ADN.L) investors own include Babcock International Group (BAB), Bayerische Motoren Werke Aktiengesellschaft (BMW), Centrica (CNA), Lloyds Banking Group (LLOY), Barclays (BARC), The Berkeley Group (BKG), Oshkosh (OSK), Vanquis Banking Group (PFG), Rio Tinto Group (RIO) and Aviva (AV).
How do I buy shares of 1724525 (ADN.L)?: Shares of ADN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ADN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

1724525 (ADN.L) (ADN) Share Price, News & Analysis

About 1724525 (ADN.L) Stock (LON:ADN)

ADN Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ADN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info